​Darren Feldman, MD, assistant attending physician for the Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, discusses how to properly treat neutropenic fever as a toxicity stemming from chemotherapy treatment.
Darren Feldman, MD
Advertisement
Articles by Darren Feldman, MD
​Darren Feldman, MD, discusses dose intensification in patients with advanced germ cell tumors who are not responding to BEP chemotherapy.
Advertisement
Latest Updated Articles
Dr. Darren Feldman on the Drawbacks of Dose Intensification for Advanced Germ Cell TumorsPublished: January 13th 2016 | Updated:
- Dr. Darren Feldman on Treating Patients Who Develop Neutropenic Fever
Published: February 4th 2016 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
